Emdeon Supports Controlled Substances Security Standards for ePrescribing

Emdeon Inc. (NYSE: EM), a leading provider of healthcare revenue and payment cycle management solutions, announced its support for the approval of security standards for the electronic prescribing (ePrescribing) of controlled substances and its commitment to assist the U.S. Drug Enforcement Administration (DEA) and the healthcare industry in implementation of the Interim Final Rule for ePrescribing controlled substances. Read more...

Visit other PMG Sites:

PMG360 is committed to protecting the privacy of the personal data we collect from our subscribers/agents/customers/exhibitors and sponsors. On May 25th, the European's GDPR policy will be enforced. Nothing is changing about your current settings or how your information is processed, however, we have made a few changes. We have updated our Privacy Policy and Cookie Policy to make it easier for you to understand what information we collect, how and why we collect it.